These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 16580840)
1. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Silveira PA; Grey ST Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840 [TBL] [Abstract][Full Text] [Related]
2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
3. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557 [TBL] [Abstract][Full Text] [Related]
4. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575 [TBL] [Abstract][Full Text] [Related]
5. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
6. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704 [TBL] [Abstract][Full Text] [Related]
7. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. DiLorenzo TP; Serreze DV Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363 [TBL] [Abstract][Full Text] [Related]
8. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843 [TBL] [Abstract][Full Text] [Related]
9. Absence of T cell tolerance to pancreatic islet cells. Burtles SS; Trembleau S; Drexler K; Hurtenbach U J Immunol; 1992 Sep; 149(6):2185-93. PubMed ID: 1355504 [TBL] [Abstract][Full Text] [Related]
10. Development of insulitis and diabetes in B cell-deficient NOD mice. Yang M; Charlton B; Gautam AM J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752 [TBL] [Abstract][Full Text] [Related]
11. B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Brodie GM; Wallberg M; Santamaria P; Wong FS; Green EA Diabetes; 2008 Apr; 57(4):909-17. PubMed ID: 18184927 [TBL] [Abstract][Full Text] [Related]
12. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related]
13. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes. Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184 [TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells in type 1 diabetes. Tsai S; Shameli A; Santamaria P Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164 [TBL] [Abstract][Full Text] [Related]
15. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094 [TBL] [Abstract][Full Text] [Related]
16. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333 [TBL] [Abstract][Full Text] [Related]
17. High efficiency presentation of TNP-conjugated islet antigen to islet-specific T cells by a hybrid B cell line expressing TNP-specific surface Ig. Wegmann D; Norbury-Glaser M; Bergman B; Haskins K J Immunol; 1992 Jul; 149(1):77-82. PubMed ID: 1318906 [TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes. Young DL; Ramanujan S; Kreuwel HT; Whiting CC; Gadkar KG; Shoda LK Ann N Y Acad Sci; 2006 Oct; 1079():369-73. PubMed ID: 17130581 [TBL] [Abstract][Full Text] [Related]
20. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]